Cyclerion Therapeutics Q1 EPS $(0.76) Down From $(0.56) YoY

Benzinga Newsdesk www.benzinga.com Negative 97.2%

Neg 97.2% Neu 0% Pos 0%

Cyclerion Therapeutics (NASDAQ:CYCN) reported quarterly losses of $(0.76) per share. This is a 35.71 percent decrease over losses of $(0.56) per share from the same period last year.